Actively Recruiting
Group Medical Visits for Patients With Dyslipidemia
Led by Université de Sherbrooke · Updated on 2026-04-22
288
Participants Needed
1
Research Sites
243 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Physicians' interventions to promote the improvement of lifestyle habits have been shown to be effective. However, such interventions remain underutilized due to barriers such as lack of time, confidence, and compensation. Group medical visits (GMVs) can help overcome several of these barriers and effectively improve clinical indicators as well as patients' quality of life. GMVs could also reduce pressure on the healthcare system by improving access to primary care through a more efficient use of resources. The literature suggests that GMVs can be effective in improving access to care and reducing disease complications for patients with several conditions and risk factors, but they have not been assessed specifically among patients with dyslipidemia, which is at the origin of most cases of cardiovascular diseases. In this context, GMVs will be implemented among 144 patients with dyslipidemia. The objective for this project is to evaluate implementation of GMVs. The implementation evaluation will follow the RE-AIM framework. These steps will position the research team to develop more complex and large-scale studies in lifestyle medicine. In the meantime, the project will contribute to improve access to primary care for the prevention of cardiovascular diseases.
CONDITIONS
Official Title
Group Medical Visits for Patients With Dyslipidemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of dyslipidemia according to Canadian Cardiovascular Society guidelines, including intermediate cardiovascular risk (10-19.9%) with LDL-C 65 3.5 mmol/L, or non-HDL-C 65 4.2 mmol/L, or ApoB 65 1.05 g/L
- Age 40 years or older
You will not qualify if you...
- Unable to participate in group medical visit sessions or provide informed consent
- Mental health condition limiting benefit from group sessions (e.g., severe dementia or acute psychiatric decompensation in past 6 months)
- Diagnosis of terminal illness or life expectancy under 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Unité de médecine familiale du Grand-Moncton
Dieppe, New Brunswick, Canada, E1A1G6
Actively Recruiting
Research Team
M
Mathieu Belanger, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here